SERPINA3 and cancer: Serum and gastric secretion concentrations of serine protease inhibitors alpha-1-antitrypsin and alpha-1-antichymotrypsin have been found to significantly increase during the early stages of similar cancers such as gastric and colorectal cancer [28].